Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells

被引:934
作者
Lund, J
Sato, A
Akira, S
Medzhitov, R
Iwasaki, A
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[3] Osaka Univ, SORST, Japan Sci & Technol Corp, Microbial Dis Res Inst,Dept Host Def, Suita, Osaka 5650871, Japan
关键词
type I interferons; CpG motif; innate immunity; virus infection; DNA virus;
D O I
10.1084/jem.20030162
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmacytoid dendritic cells (pDCs) have been identified as a potent secretor of the type I interferons (IFNs) in response to CpG as well as several viruses. In this study, we examined the molecular mechanism of virus recognition by pDCs. First, we demonstrated that the CD11c(+)Gr-1(int)B220(+) pDCs from mouse bone marrow secreted high levels of IFN-alpha in response to either live or UV-inactivated Herpes simplex virus-2 (HSV-2). Next, we identified that IFN-alpha secretion by pDCs required the expression of the adaptor molecule MyD88, suggesting the involvement of a Toll-like receptor (TLR) in HSV-2 recognition. To test whether a TLR, mediates HSV-2-induced IFN-alpha. secretion from pDCs, various knockout mice were examined. These experiments revealed a clear requirement for TLR9 in this process. Further, we demonstrated that purified HSV-2 DNA can trigger IFN-alpha secretion from pDCs and that inhibitory CpG oligonucleotide treatment diminished HSV-induced IFN-alpha secretion by pDCs in a dose-dependent manner. The recognition of HSV-2 by TLR9 was mediated through an endocytic pathway that was inhibited by chloroquine or bafilomycin A1. The strict requirement for TLR9 in IFN-alpha secretion was further confirmed by the inoculation of HSV-2 in vivo. Therefore, these results demonstrate a novel mechanism whereby the genomic DNA of a virus can engage TLR9 and result in the secretion of IFN-alpha by pDCs.
引用
收藏
页码:513 / 520
页数:8
相关论文
共 34 条
  • [1] Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
    Adachi, O
    Kawai, T
    Takeda, K
    Matsumoto, M
    Tsutsui, H
    Sakagami, M
    Nakanishi, K
    Akira, S
    [J]. IMMUNITY, 1998, 9 (01) : 143 - 150
  • [2] Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO
  • [3] 2-U
  • [4] Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology
    Asselin-Paturel, C
    Boonstra, A
    Dalod, M
    Durand, I
    Yessaad, N
    Dezutter-Dambuyant, C
    Vicari, A
    O'Garra, A
    Biron, C
    Brière, F
    Trinchieri, G
    [J]. NATURE IMMUNOLOGY, 2001, 2 (12) : 1144 - 1150
  • [5] Virus-induced interferon α production by a dendritic cell subset in the absence of feedback signaling in vivo
    Barchet, W
    Cella, M
    Odermatt, B
    Asselin-Paturel, C
    Colonna, M
    Kalinke, U
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (04) : 507 - 516
  • [6] Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: Dependency on antigen dose and differential toll-like receptor ligation
    Boonstra, A
    Asselin-Paturel, C
    Gilliet, M
    Crain, C
    Trinchieri, G
    Liu, YJ
    O'Garra, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (01) : 101 - 109
  • [7] Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs
    Brawand, P
    Fitzpatrick, DR
    Greenfield, BW
    Brasel, K
    Maliszewski, CR
    De Smedt, T
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (12) : 6711 - 6719
  • [8] Estimates of the incidence and prevalence of sexually transmitted diseases in the United States
    Cates, W
    [J]. SEXUALLY TRANSMITTED DISEASES, 1999, 26 (04) : S2 - S7
  • [9] Interferon α/β and interleukin 12 responses to viral infections:: Pathways regulating dendritic cell cytokine expression in vivo
    Dalod, M
    Salazar-Mather, TP
    Malmgaard, L
    Lewis, C
    Asselin-Paturel, C
    Brière, F
    Trinchieri, G
    Biron, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (04) : 517 - 528
  • [10] Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391